Option Care Health Inc (OPCH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $4.75B
Last updated: Nov 17, 2026 at 4:21 PM ET
Option Care Health Inc (OPCH) Statistics
Option Care Health (OPCH) has a market cap of $4.75B and an enterprise value of $5.61B. Its share count is down 7.44% from a year earlier. Its trailing P/E of 18.5x is below its 5-year median of 25.7x.
Total Valuation
Enterprise value is 18.08% above the market cap, as debt exceeds cash.
| Market Cap | $4.75B |
|---|---|
| Enterprise Value | $5.61B |
| Latest price (Nov 17, 2026) | $31.63 |
Key Dates
The next earnings report is expected on Jan 11, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Jan 11, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.8x and 3.6x. Its year-end P/E ranged from 18.1x to 142.2x from 2020 to 2025.
| P/E Ratio | 18.5x |
|---|---|
| Forward P/E | 16.4x |
| P/S Ratio | 0.8x |
| Forward P/S | 0.8x |
| P/B Ratio | 3.6x |
| P/FCF Ratio | 16.8x |
| P/OCF Ratio | 14.7x |
| PEG Ratio | 1.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 13.4x EBITDA and 19.9x free cash flow.
| EV / Earnings | 26.1x |
|---|---|
| EV / Sales | 1.0x |
| EV / EBITDA | 13.4x |
| EV / EBIT | 16.4x |
| EV / FCF | 19.9x |
Price Statistics
The stock is up 11.33% over 52 weeks and trades 11.45% above its 50-day average.
| Beta (1Y) | -0.02 |
|---|---|
| 52-Week Change | +11.33% |
| 1-Month Change | +1.35% |
| 3-Month Change | +35.46% |
| 6-Month Change | +51.63% |
| 5-Year Change | +16.47% |
| 10-Year Change | +195.82% |
| Total Return (1Y) | +11.33% |
| Total Return (3Y CAGR) | +2.57% |
| Total Return (5Y CAGR) | +3.57% |
| Return vs SPY (1Y) | +0.29% |
| Max Drawdown (1Y) | -46.65% |
| Max Drawdown (3Y) | -46.65% |
| Sharpe Ratio (1Y) | 0.22 |
| Correlation with SPY (1Y) | -0.01 |
| 50-Day Average | $28.38 |
| 200-Day Average | $26.09 |
| 52-Week Range | $18.01 to $36.80 |
| RSI (14 Days) | 72.3 |
| Average Volume (20 Days) | 3.52M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.54x current liabilities, and total debt is 0.87x shareholder equity.
| Current Ratio | 1.54x |
|---|---|
| Quick Ratio | 1.06x |
| Debt / Equity | 0.87x |
| Debt / EBITDA | 2.77x |
| Debt / FCF | 4.11x |
| Interest Coverage | 6.45x |
Returns and Efficiency
Return on invested capital is 10.02% over the last 12 months, against a 5-year average of 9.41%.
| Return on Equity (ROE) | 16.25% |
|---|---|
| Return on Assets (ROA) | 6.19% |
| Return on Invested Capital (ROIC) | 10.02% |
| Return on Capital Employed (ROCE) | 13.00% |
| ROE (5Y Average) | 14.46% |
| ROA (5Y Average) | 6.07% |
| ROIC (5Y Average) | 9.41% |
| Asset Turnover | 1.65x |
| Inventory Turnover | 11.53x |
| Receivables Turnover | 11.31x |
| Cash Conversion Cycle | 13 days |
Taxes
Income tax took 27.15% of pretax income over the last 12 months.
| Income Tax (TTM) | $80.21M |
|---|---|
| Effective Tax Rate | 27.15% |
Scores
OPCH has an Altman Z-Score of 3.88, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.88 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $5.75B over the last 12 months is up 4.01% from the 12 months before.
| Revenue | $5.75B |
|---|---|
| Revenue Growth (YoY) | +4.01% |
| Gross Profit | $1.10B |
| Operating Income | $338.40M |
| Pretax Income | $295.41M |
| Net Income | $215.19M |
| EBITDA | $417.28M |
| EBIT | $341.31M |
| Reported EPS (TTM) | $1.71 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 37.93% of the $3.48B in total assets.
| Cash and Equivalents | $299.09M |
|---|---|
| Total Debt | $1.16B |
| Net Debt | $858.74M |
| Net Debt Per Share | $5.73 |
| Working Capital | $461.56M |
| Shareholder Equity | $1.32B |
| Book Value Per Share | $8.84 |
| Tangible Book Value | -$563.63M |
| Total Assets | $3.48B |
| Total Liabilities | $2.15B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $40.45M of capital spending, operating cash flow left $281.65M of free cash flow.
| Operating Cash Flow | $322.10M |
|---|---|
| Capital Expenditures | $40.45M |
| Free Cash Flow | $281.65M |
| FCF Per Share | $1.88 |
| Depreciation and Amortization | $75.97M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 5.88%, against a 5-year average of 6.27%.
| Gross Margin | 19.07% |
|---|---|
| Operating Margin | 5.88% |
| Pretax Margin | 5.14% |
| Net Margin | 3.74% |
| EBITDA Margin | 7.25% |
| EBIT Margin | 5.93% |
| FCF Margin | 4.90% |
| Gross Margin (5Y Average) | 21.40% |
| Operating Margin (5Y Average) | 6.27% |
| Net Margin (5Y Average) | 4.40% |
Growth
Revenue grew 12.72% a year over 3 years, and EPS 27.49% a year.
| Revenue Growth (3Y CAGR) | +12.72% |
|---|---|
| Revenue Growth (5Y CAGR) | +13.25% |
| EPS Growth (3Y CAGR) | +27.49% |
| EPS Growth (5Y CAGR) | +73.31% |
| FCF Growth (3Y CAGR) | -2.21% |
| FCF Growth (5Y CAGR) | +16.65% |
| Operating Income Growth (3Y CAGR) | +12.04% |
| Book Value Per Share Growth (2Y CAGR) | +1.86% |
Dividends and Yields
OPCH does not pay a dividend. Its free cash flow yield is 5.94%.
| Earnings Yield | 5.41% |
|---|---|
| FCF Yield | 5.94% |
| Buyback Yield | 2.01% |
| Shareholder Yield | 2.01% |
Stock Splits
The last split was a 1-for-4 reverse split on Feb 3, 2020.
| Last Split Date | Feb 3, 2020 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:4 |
Peer Position
Against 12 similar companies, OPCH has the 8th highest P/E and the 10th highest P/S.
P/E RatioPeer median 21.7x
P/S RatioPeer median 1.2x
ROICPeer median 13.38%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.19%
| P/E Ratio | 18.5x vs 21.7x median |
|---|---|
| P/S Ratio | 0.8x vs 1.2x median |
| ROIC | 10.02% vs 13.38% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +4.01% vs +7.19% median |
Analyst Forecast
Consensus estimates put revenue growth at 4.34% and EPS growth at 10.08% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +4.34% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +10.08% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OPCH
What is OPCH's market cap?
Option Care Health has a market cap of $4.75B. Its enterprise value, which adds debt and subtracts cash, is $5.61B.
What is OPCH's P/E ratio?
Option Care Health has a trailing P/E ratio of 18.5x and a forward P/E of 16.4x.
How many shares of OPCH are outstanding?
Option Care Health has 149.79M shares outstanding. The count is down 7.44% from a year earlier.
Does OPCH pay a dividend?
No. Option Care Health does not pay a dividend.
How much debt does OPCH have?
Option Care Health has $1.16B of total debt and $299.09M of cash and equivalents, a net debt position of $858.74M.
OPCH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts